ELISA evaluation of patient seroreactivities to L. infantum recombinant proteins and LiSLA. Sera from patients with visceral leishmaniasis (VL, n = 10), cutaneous leishmaniasis (CL, n = 10), tuberculosis (TB, n = 10), and malaria (n = 6) and sera from healthy controls in the United States (n = 10) were used. The mean and standard error of the mean of the OD values for each group are shown.